摘要
目的:研究维拉帕米(Ver)是否能抑制去甲肾上腺素(NE)诱导的培养大鼠心肌细胞β受体下调及其可能机制.方法:β受体密度用[3H]DNA放射配基标记法,细胞内游离钙用钙离子荧光探针Fura2AM法测定.结果:Ver能明显降低培养大鼠心肌细胞内游离钙水平,增加β受体密度;NE增加细胞内游离钙水平,降低β受体密度;Ver能明显抑制NE引起的细胞内游离钙增加和β受体密度的降低.结论:Ver能增加正常心肌细胞β受体密度,抑制NE产生的心肌β受体下调.
AIM: To determine whether verapamil (Ver) inhibits norepinephrine (NE)induced β adrenoceptors downregulation in cultured rat cardiomyocytes. METHODS: Dihydroalprenolol (DHA) radiobinding assay was used to measure β adrenoceptor density, fluorescent indicator Fura 2AM was used to estimate levels of free cytosolic calcium ([Ca2+]i). RESULTS: Ver reduced [Ca2+]i and increased β adrenoceptor density, NE increased [Ca2+]i and reduced β adrenoceptor density of cultured cardiomyocytes, these effects were time and concentration dependent. Ver inhibited the above effects of NE. CONCLUSIONS: Ver increased β adrenoceptor density and inhibited NEinduced β adrenoceptor downregulation of cardiomyocytes.
出处
《中国药理学报》
CSCD
1998年第2期148-150,共3页
Acta Pharmacologica Sinica
关键词
Β肾上腺素能
受体
维拉帕米
去甲肾上腺素
心肌
beta adrenergic receptors
verapamil
calcium
norepinephrine
myocardium
cultured cells
dihydroalprenolol
Fura2